Novel Ablation Catheters for Atrial Fibrillation

Area of Science:

• Cardiology
• Medical Devices
• Electrophysiology

Background:

• Atrial fibrillation (AF) ablation traditionally uses thermal energy, risking collateral damage to adjacent cardiac structures.
• Pulsed field ablation (PFA) emerges as a non-thermal alternative, offering potential for tissue selectivity.

Purpose of the Study:

• To review the current status and potential of pulsed field ablation (PFA) for atrial fibrillation (AF) treatment.
• To highlight PFA's advantages over thermal ablation modalities and discuss ongoing investigations.

Main Methods:

• Review of current and investigational pulsed field ablation (PFA) systems for AF ablation.
• Analysis of reported acute success rates, complication incidence, and procedure times.
• Evaluation of pulmonary vein (PV) durability from clinical studies with chronic remapping.

Main Results:

• PFA demonstrates favorable acute success rates and low complication incidence, regardless of catheter design (single-shot or focal).
• Optimized pulsed field waveforms have achieved over 90% pulmonary vein (PV) durability in clinical studies.
• PFA's non-thermal mechanism minimizes damage to non-target cardiac tissues.

Conclusions:

• Pulsed field ablation (PFA) presents a promising, potentially safer alternative for atrial fibrillation (AF) ablation due to its non-thermal, tissue-selective properties.
• Ongoing research and careful monitoring are essential as PFA technology evolves and its clinical application broadens.